Smartfish conducts research on nutrition drinks for COPD patients in Sweden
World COPD Day is an annual event organised by the organisation GOLD (Global Initiative for Chronic Obstructive Lung Disease) to increase awareness on chronic obstructive lung disease (COPD) worldwide.
Many patients suffering from COPD are malnourished. Weight loss for patients with COPD is often associated with loss of muscle mass, reduced fat depots, osteoporosis, reduced muscle strength and worsened function in the diaphragm muscle which is important for respiration. Malnutrition (cachexia) along with COPD is even linked to systemic inflammation and increased risk of infection due to the weakened immune system.
Malnutrition accompanying COPD can be treated with a high quality nutritional supplement together with physical activity.
Smartfish Nutrifriend nutrition drinks are developed for special medical purposes: for patients with disease related malnutrition, for example patients with COPD. The drinks are based on juice and have a high content of omega-3 as well as high levels of protein.
Smartfish is currently conducting a research study at five clinics in Sweden, where Nutrifriend is given to patients with moderate to severe COPD. Recruitment of patients is still ongoing.
Further information about the ongoing COPD study is found on the following link:
Jens Nordahl, CEO of Smartfish, says the company is confident that Nutrifriend in the future will be a natural part of the treatment of malnourished CODP patients. The company has also recently initiated a similar study in patients with lung cancer, which is another patient group where Nutrifriend is anticipated to have a beneficial effect on the symptoms caused by malnutrition.
For further information, please contact:
Jens Nordahl, CEO
Gaustadalléen 21, 0349 Oslo
Tel: +47 22519880,
Mob: +47 99629999
For questions about our products:
Trine Kristin Nystrøm, Nordic Area Manager Clinical Nutrition
Mob: +47 91770967
Joakim Holmqvist, Product Specialist
Tel. +46 070-582 3772
Smartfish is a biotechnology company developing advanced medical and sports related nutrition products. The medical products are drinks intended for patients with cancer, cachexia and immune related diseases and are registered in several markets. The company has a broad clinical research programme, with focus on products within cachexia for patients with COPD and cancer and within MCI (early Alzheimers disease) and other psychiatric diseases.